Condition: Advanced Lung Non-Small Cell Carcinoma · Recurrent Lung Non-Small Cell Carcinoma · Stage IIIB Lung Non-Small Cell Cancer AJCC v7 · Sponsor: National Cancer Institute (NCI)
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Anchorage Associates in Radiation Medicine | Anchorage, Alaska, United States | Active Not Recruiting |
| Anchorage Radiation Therapy Center | Anchorage, Alaska, United States | Active Not Recruiting |
| Alaska Breast Care and Surgery LLC | Anchorage, Alaska, United States | Active Not Recruiting |
| Alaska Oncology and Hematology LLC | Anchorage, Alaska, United States | Active Not Recruiting |
| Alaska Women's Cancer Care | Anchorage, Alaska, United States | Active Not Recruiting |
| Anchorage Oncology Centre | Anchorage, Alaska, United States | Active Not Recruiting |
| Katmai Oncology Group | Anchorage, Alaska, United States | Active Not Recruiting |
| Providence Alaska Medical Center | Anchorage, Alaska, United States | Active Not Recruiting |
| Fairbanks Memorial Hospital | Fairbanks, Alaska, United States | Recruiting |
| Mercy Hospital Fort Smith | Fort Smith, Arkansas, United States | Recruiting |
| CARTI Cancer Center | Little Rock, Arkansas, United States | Recruiting |
| Providence Saint Joseph Medical Center/Disney Family Cancer Center | Burbank, California, United States | Active Not Recruiting |
+ 333 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03191149